HMG-CoA reductase (HMGR) undergoes regulated degradation as part of feedback control of the sterol pathway. In yeast the stability of the Hmg2 isozyme of HMGR is controlled by the 20 carbon isoprenoid geranylgeranyl pyrophosphate (GGPP): increasing levels of GGPP causes more efficient degradation by the HRD pathway, allowing feedback regulation of HMGR. The HRD pathway is a conserved quality control pathway critical for the ER-associated degradation of misfolded ER proteins. We have explored the action of GGPP in HRD-dependent Hmg2 degradation. GGPP was highly potent as a regulatory molecule in vivo, and in vitro, GGPP altered Hmg2 folding at nanomolar concentrations.
INTRODUCTION
Protein quality control includes a variety of mechanisms to ensure tolerably low levels of misfolded proteins in the living cell. Among these, selective degradation of misfolded, damaged or un-partnered proteins is often employed for removal of these potentially toxic species. One of the best characterized pathways of degradative quality control is ER-associated degradation (ERAD), entailing a group of ubiquitin-mediated pathways that degrade both lumenal and integral membrane proteins of the endoplasmic reticulum (ER) (1) (2) (3) (4) . All degradative quality control pathways show a remarkable juxtaposition in their action. They are all highly specific for misfolded versions of the substrate proteins, yet they recognize a wide variety of distinct and unrelated substrates (5, 6) . This "broad selectivity" is based on the ability of the ubiquitination enzymes to recognize or respond to specific structural hallmarks of misfolding shared by a wide variety of client substrates. The details and restrictions of these recognition features are still being discovered due to the apparently wide range of ways that E3 ligases can detect their clients (5, (7) (8) (9) .
The remarkable selectivity for misfolded proteins positions degradative quality control as a powerful tactic for physiological control of normal proteins.
It is now clear that a number of cases exist where a normal protein can enter a bone fide quality control pathway to bring about its physiological regulation (10-16). The best studied example of this sort of control is the regulated degradation of Our studies of sterol regulation in S. cerevisiae show that the HRD ERAD pathway mediates the regulated degradation of the Hmg2 isozyme of HMGR. The HRD pathway is centrally involved in mitigating ER stress through ubiquitin-mediated degradation of a wide variety of misfolded, ER resident lumenal and integral membrane proteins (12, (17) (18) (19) . The primary signal for Hmg2 degradation is the 20 carbon sterol pathway product geranylgeranyl pyrophosphate (GGPP) ( Fig 1A) which is produced during normal cell anabolism and is thus a fiduciary indicator of sterol pathway activity (20) . When levels of GGPP are high, HRD dependent degradation of Hmg2 increases, and when GGPP levels are low, Hmg2 becomes more stable, thus effecting feedback control at the level of enzyme stability. It was initially surprising that the broadly used HRD quality control pathway is required for the precisely regulated degradation of normal Hmg2.
Because the HRD pathway functions to remove misfolding proteins, we had previously posited that GGPP functions by promoting a change in the structure of Hmg2 to a better HRD pathway substrate, thus employing the selectivity of the HRD machinery for purposes of physiological regulation. The studies herein test and explore that idea.
We found that indeed GGPP directly influenced the structure of the Hmg2 multispanning anchor, in the low-to-mid nanomolar range. These potent actions of GGPP were highly specific, and in fact were antagonized by a close GGPP analogue both in vivo and in vitro. Furthermore, the effects of GGPP were blocked by a variety of chemical chaperones, indicating that this molecule causes remediable misfolding of the Hmg2 structure to promote HRD recognition. Taken together, these studies lead to a natural model of regulated quality control as a form of allostery that may be widely employed in biology to harness the intrinsic specificity of the many branches of degradative quality control. Because this axis of regulation appears to be based on reversible misfolding due to specific ligand binding, we have given it the name "mallostery" to reflect both the elements of misfolding implied by the prefix, and the action of a selective regulatory ligand that hallmarks allosteric control of many enzymes and other proteins.
RESULTS
Specificity and potency of isoprenoids that stimulate Hmg2 degradation-In our earlier work, we tested the effects of a variety of sterol pathway molecules on Hmg2 stability (20, 21) . We found that only the 20-carbon isoprenoid geranylgeranyl pyrophosphate (GGPP) caused Hmg2 degradation in vivo when added to culture medium (Garza et al., 2009 ). This surprising ability of exogenous GGPP to stimulate Hmg2 degradation has been a useful feature for study of this regulatory signal (22, 23) . Because this response is part of a selective negative feedback loop, we posited that the GGPP signal would be specific, physiologically relevant, and highly potent. To more systematically evaluate these ideas, we first performed dose response experiments on pathway isoprenoids alone and in combination.
We examined the effects of candidate isoprenoids on Hmg2 stability in vivo using flow cytometry on cells expressing Hmg2-GFP, which undergoes regulated degradation identical to the native enzyme (24) , but provides no additional enzymatic contribution to signal production. Each was tested at a variety of concentrations by direct addition to Because GGPP is synthesized by addition of the 5 carbon IPP ( Fig 1A) to FPP, we also tested if addition of both FPP and either of the interconvertible precursors might simulate direct addition of GGPP by allowing synthesis of this regulator from these precursors. Accordingly, we also treated cells simultaneously with the combinations IPP and FPP, or GPP and FPP.
Neither of these co-additions had any effect.
These results indicated a clear structure-function relationship for GGPP as a degradation signal, since similar molecules did not act to stimulate Hmg2 degradation. We were curious how stringent the structural features of GGPP were, so we next tested two close analogues of GGPP: 2F-GGPP and GGSPP ( Fig 3A) . Despite the striking similarity to GGPP, neither of these molecules stimulated Hmg2 degradation in vivo at even very high concentrations. Thus, the in vivo effect of GGPP on Hmg2 degradation appeared to be highly specific. The high specificity of GGPP the in vivo assay could have a variety of explanations so we turned to our previously employed in vitro assay to directly evaluate the action of GGPP on regulated stability of Hmg2.
In vitro analysis of GGPP action on Hmg2-Our early studies described a limited proteolysis assay for studying the effects of small molecules and expressed proteins on the structure of the Hmg2 transmembrane domain (25, 26) . The assay uses myc L -Hmg2-GFP, a version of Hmg2-GFP with an added single myc tag inserted into the first luminal loop of the transmembrane domain ( Fig   2A) . The exact placement of lumenal tag along the Hmg2 sequence provides two key features: first, it does not perturb in vivo regulation of the resulting protein. Second, because the myc tag is present in the lumenal space, complete proteolysis of the tagged Hmg2 can be accomplished by addition of proteases to the cytoplasmic side of ER-derived microsomes without loss of myc signal (25) . Because ER microsomes from yeast are almost completely cytosol-side-out (27) , expression of myc L -Hmg2-GFP allows facile analysis of structural features of microsomal Hmg2-GFP with a simple limited proteolysis assay (22, 25, 26, 28) .
When microsomes isolated from cells expressing myc L -Hmg2-GFP are treated with a low concentration of trypsin, immunoblotting the protected myc epitope after SDS-PAGE reveals a characteristic time-dependent pattern of proteolyzed fragment production ( Fig 2B) .
Because the myc tag is protected, the total myc immunoblotting signal intensity remains unchanged. We developed this assay to explore how signals from the sterol pathway affect the structure of Hmg2 to render it more susceptible to the HRD quality control pathway (26) . In those early studies we found that the rate of myc L -Hmg2-GFP proteolysis was altered by manipulations that affect the in vivo stability of the protein, such that in vitro proteolysis occurred more rapidly when microsomes were prepared from strains where the degradation signals are high (26) . In vivo, Hmg2 or Hmg2-GFP is strongly stabilized by chemical chaperones (29) . Similarly, proteolysis of microsomal myc L -Hmg2-GFP is drastically slowed by addition of the chemical chaperone glycerol, and this structural change is fully reversible (25) . We employed this in vitro structural assay to explore the possibility that sterol pathway signals directly affected the structure of Hmg2 to allow regulated degradation.
In those studies, we showed that the 15 carbon neutral isoprenoid farnesol (FOH) caused significant acceleration of in vitro myc L -Hmg2-GFP trypsinolysis, again preserving the cleavage pattern but altering the kinetics (26) . This effect of FOH is fully reversible. Furthermore, mutants of Hmg2-GFP that do not respond to in vivo degradation signals, including a substitution of a small number of amino acids known as "TYFSA", or a single point S215A point mutant of a highly conserved residue of the sterol-sensing domain (SSD), do not respond to farnesol in the limited proteolysis assay (22, 26) . Although those results were intriguing and biologically appropriate, the biological role of farnesol per se was unclear.
Although there was a clear structure-activity relationship for farnesol in the proteolysis assay, the concentrations required to cause the in vitro effects were very high (EC 50 ~ 100 uM), and farnesol is extremely toxic to yeast. In the times since these studies, we discovered that the bona fide physiological regulator was the normally made isoprenoid GGPP, which also causes the structural transition of Hmg2-GFP in the proteolysis assay (20). Accordingly we returned to this assay to evaluate the specificity and potency of GGPP in a more controlled setting.
In striking contrast to FOH, we found that GGPP was a potent modifier of Hmg2 structure. GGPP Fig 2F) . Furthermore, the treated and then washed microsomes remained competent for the GGPP-induced structural transition: when GGPP was added back to the washed microsomes, Hmg2-GFP again became more susceptible to proteolysis, and to the same extent as the original exposure ( Fig 2G) .
Antagonism of GGPP action in vitro and in vivo-
The GGPP analogues 2F-GGPP and GGSPP had no ability to stimulate Hmg2-GFP degradation in vivo ( Fig 4A,C) , nor alter Hmg2-GFP structure in the limited proteoloysis assay ( Fig 3B) . The high potency and specificity of GGPP, and its ability to directly and reversibly alter the structure of Hmg2-GFP made us wonder if it acts as a ligand, causing a structural change by specific interaction with the Hmg2 transmembrane region at a particular binding site, similar to allosteric regulation of enzymes by regulatory metabolites. Accordingly, we asked if an excess of either of the highly similar, inactive analogues might antagonize the effects of GGPP. Each was tested for an ability to block the structural effect of a low concentration of GGPP by co-incubation with an excess of analog. As expected, the test doses of either analog had no effect on myc L -Hmg2-GFP ( Fig 3B) .
However, the presence of a 15-fold molar excess of GGSPP clearly antagonized the structural effect of GGPP. Interestingly, only one of the analogues had this effect; the 2F-GGPP was simply inactive in an identical experiment ( Fig 3C) . This is particularly important since both molecules have very similar chemistry and amphipathicity, both being developed to block the same class of enzymes (33, 34) . Nevertheless, only GGSPP antagonized the GGPP-induced structural effects on myc L -Hmg2-GFP.
We further explored the antagonistic action of GGSPP by examining its effects on GGPPinduced Hmg2 degradation in vivo. Because simultaneous addition of both GGPP and GGSPP could also have interactions on the unknown influx mechanism that appears to operate in yeast, we explored the effect of the inactive analogues on the endogenous GGPP degradation signal, which we have extensively characterized (20, 24). We first simply added each analogue to a strain with sufficient flux through the sterol pathway to produce the needed GGPP signal for Hmg2-GFP degradation. Specifically, we examined the effect of addition of inactive analogue on the Hmg2-GFP levels during a three hours incubation period. The effects of the analogues were small, but consistent with the in vitro effects of each: 2F-GGPP had no effect, while the GGSPP caused a small but reproducible increase in Hmg2-GFP steady-state ( Fig 4A, left) , implying that the added antagonist can block the degradation-stimulating effect of endogenous GGPP. Importantly, an identical experiment with the similarly degraded but unregulated TFYSA mutant of Hmg2-GFP showed no effect of the GGSPP antagonist on steady state levels, indicating that its effect was due to altering the response to GGPP signal, rather than effects on the HRD pathway itself (Fig 4A, right).
To further evaluate in vivo antagonism, we Testing GGPP as a ligand that promotes regulated misfolding-We have previously proposed the idea that regulated Hmg2 degradation entails a programed or regulated change to a more unfolded form, thus enhancing the probability of entry into the HRD quality control pathway (22, 26, 36) . Another indicator of protein misfolding is increased susceptibility to thermal denaturation.
We previously showed that treatment with high Since the GGPP-caused structural transition is reversible and antagonizable, we drew an analogy to allostery. By this model, GGPP binding to a specific site would alter the structure of Hmg2 to allow a more unfolded structure that is amenable to better recognition by the HRD machinery and reversible with chemical chaperones, but is not grossly misfolded. Although allosteric transitions are usually discussed with respect to enzyme kinetics or related protein functions, it is easily conceivable that a similar alteration in structure could render a substrate more or less susceptible to engagement of quality control machinery. Nearly all allosteric proteins are multimeric, and many require this structural feature for allostery to occur (37) . We tested whether Hmg2 exists as a multimer using co-immunoprecipitation, modifying our method to analyze in vivo interactions of Hmg2 and other proteins (23, 38, 39) . Specifically, we co-expressed Hmg2 tagged with GFP and Hmg2 with a myc tag in the linker domain in the same yeast strain. Co-expressing cells were subjected to non-detergent lysis and microsomes were prepared. Microsomes were then solubilized and Hmg2-GFP was immunoprecipitated. When both tagged constructs were co-expressed in the same strain, immunoprecipitation of Hmg2-GFP caused coprecipitation of 1myc-Hmg2, demonstrating that Hmg2 forms multimeric structures ( Fig 6A) .
When only Hmg2-GFP or 1myc-Hmg2 was expressed in a strain, we were unable to detect the other tag in input lysates or immunoprecipitations ( Fig 6A) .
We asked if GGPP could affect Hmg2 multimerization. We repeated the co- 
DISCUSSION
In these studies we sought to understand the GGPP-mediated regulation of Hmg2 ERAD. This to target pharmacologically, and have in fact been referred to as the "undruggable proteome" (56).
The UPS system has already been tapped as a tool for pharmacological targeting of these undruggable protein through regulated degradation.
Two main strategies have emerged so far:
targeting proteins directly to specific E3 ligases, such as VHL (57), and targeting proteins with ligands fused to a long hydrophobic molecule, or "greasy patch," to mimic a misfolded protein (45) .
Directing proteins specifically to quality control by cleaver discovery of mallosteric regulators that cause selective unfolding may offer another approach for targeting the undruggable proteome, and one that nature has clearly already discovered during evolution. Yeast strains and plasmids-Yeast strains ( Table 1) and plasmids ( 
EXPERIMENTAL PROCEDURES
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Flow cytometry-Flow cytometry was performed as described previously (24, 58) . Briefly, yeast strains were grown in minimal media into early log phase (OD 600 <0.2) and incubated with the Thermal denaturation assay-The thermal denaturation assay was performed as described previously (26) . structure is fully reversible, and GGPP responsiveness remains after reversal. 2F:
Microsomes were washed and then treated with vehicle or GGPP (groups 1 and 2), or treated with vehicle or GGPP and then washed (groups 3 and 4). All groups were then subjected to limited proteolysis assay as described. Note that washing first did not affect response to GGPP, while washing after exposure removed effect. 2G:
Microsomes that were treated with GGPP and washed maintained their ability to respond to readdition of GGPP. Left set of microsomes was washed, then treated with GGPP (left group).
Middle set was treated with GGPP then washed, and the right group was treated with GGPP, washed, then re-treated with GGPP. All samples were then subjected to limited proteolysis assay.
Note re-addition of GGPP gave precisely the same response as first addition. 
